Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2013; 19(46): 8714-8721
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8714
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8714
Table 1 LGR5 immunostaining in gastric cancer-related gastric tissues and metastases n (%)
| Pathological type | Total, n | LGR5 expression | P value | |
| Negative | Positive | |||
| Normal tissue | 145 | 106 (73.1) | 39 (26.9) | 0.000 |
| Dysplasia grade | 53 | 26 (49.1) | 27 (50.9) | |
| Low | 25 | 8 (32.0) | 17 (68.0) | 0.019 |
| High | 28 | 18 (64.3) | 10 (35.7) | |
| TNM stage | 180 | 85 (47.2) | 95 (52.8) | |
| I-II | 71 | 27 (38.0) | 44 (62.0) | |
| III-IV | 109 | 58 (53.2) | 51 (46.8) | |
| Metastases | 15 | 4 (26.7) | 11 (73.3) | |
| Lymph node | 5 | 1 (20.0) | 4 (80.0) | |
| Liver | 10 | 3 (30.0) | 7 (70.0) | |
- Citation: Zheng ZX, Sun Y, Bu ZD, Zhang LH, Li ZY, Wu AW, Wu XJ, Wang XH, Cheng XJ, Xing XF, Du H, Ji JF. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis. World J Gastroenterol 2013; 19(46): 8714-8721
- URL: https://www.wjgnet.com/1007-9327/full/v19/i46/8714.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i46.8714